Corporate wellness programs reward you for showing up. The move from corporate wellness to cardiometabolic care begins with a workup that exists to find what the screening never looks at. If your employer's biometric screening came back normal and you still feel off, you are not imagining it. The screening was designed to produce a benefit-reporting number. It was never designed to produce a clinical picture.
We run a Cardiometabolic Optimization practice, and a meaningful share of our members arrive exactly this way: normal workplace panel, real symptoms, no clinician anywhere in the loop. Here is what the annual screening actually covers, what it skips, and what a proper workup adds.
- Workplace biometric screenings typically measure height, weight, blood pressure, glucose or A1c, and a basic lipid panel.
- They do not measure ApoB, Lp(a), hs-CRP, insulin markers, thyroid, or hormones, which is where cardiometabolic risk usually hides.
- Nearly half of people hospitalized with coronary artery disease have admission LDL under 100, which shows how much a standard cholesterol panel misses.
- A normal screening result is not a clinical evaluation; nobody who read it is monitoring you over time.
- A quarterly Biomarker Audit inside a flat-fee membership measures what the screening skips and puts a clinician behind the numbers.
What the annual screening actually measures
The standard corporate biometric screening takes about ten minutes at a table outside the conference room. It captures a short list: height, weight or BMI, waist or body-fat estimate, blood pressure, usually fasting glucose or HbA1c, and a basic lipid panel with total cholesterol, LDL, HDL and triglycerides.
That list is not useless. Blood pressure, A1c and triglycerides are real signals, and a screening that catches an A1c of 6.4 has done its one job. The problem is what the list leaves out, and the way the result gets delivered: a portal score, a wellness-points credit, and no clinician.
What the screening measures versus what the system needs
The gap, marker by marker
| Screening covers | The workup adds |
|---|---|
| Basic lipids (LDL, HDL, triglycerides) | ApoB particle count and Lp(a), the risk carriers the basic panel estimates or misses |
| Glucose or HbA1c | Fasting insulin and the insulin-resistance picture that precedes the A1c move |
| Blood pressure | hs-CRP and the inflammation layer behind blood pressure and plaque |
| Usually nothing hormonal | Full thyroid and hormone panels, which drive energy, weight and lipids |
| One point in time | The same panel every 90 days, read as a trend |
Why the standard cholesterol number misses so much
Here is the statistic that reframes every normal lipid panel. In the Get With The Guidelines analysis of 136,905 hospitalizations for coronary artery disease, almost half of admitted patients had an admission LDL below 100 mg/dL, and fewer than 2 percent had what the authors called ideal levels (the published paper is here).
Read that again from the other side: people land in the hospital with coronary disease carrying LDL numbers their screening would have stamped normal. The basic panel measures the cholesterol inside the particles. The risk lives in the number of particles, which is what ApoB counts, and in inflammation, which is what hs-CRP reads. Neither is on the screening table.
Our guide to the labs worth requesting at a metabolic checkup walks through the full list, marker by marker.
The screening also has no clinician behind it
A screening produces a number and a benefits credit. What it does not produce is a professional relationship: nobody reviews your result against your history, nobody orders a confirmatory panel when something looks borderline, nobody watches the trend next year, and nobody is reachable when you have a question in March.
That is the structural difference, and it matters more than any single marker. Risk is a trajectory, not a snapshot. A screening you take once a year, read against a population band, with no follow-up, is a snapshot of a snapshot.
If your workplace screening flagged something borderline, do not wait a year for the next one. A fasting insulin, an ApoB and a thyroid panel drawn properly will tell you more than the next two annual screenings combined.
What a real cardiometabolic workup includes
Our Biomarker Audit, included every 90 days in the membership, covers the layers the screening skips: ApoB and Lp(a) for the atherosclerotic particle burden, HbA1c plus fasting insulin for the glucose and insulin axis, a full lipid fraction, hs-CRP for inflammation, and complete thyroid and hormone panels, because energy, weight, lipids and mood all run through those systems together.
Then comes the part no screening has: a clinician who reads the whole panel against your history, explains it in plain English, and orders what comes next when something needs a second look. When a metabolic driver needs treatment, we treat it. When a GLP-1 or a hormone protocol is clinically appropriate, it is prescribed at the pharmacy's own cost, with nothing added by us.
The math, stated plainly
The membership is $299 a month. The first charge at sign-up is $598, one charge covering the first two months: the intake, the first full Biomarker Audit, the clinical protocol, and month two of care. If the clinician cannot accept you into care, the $598 hold is released and you are never charged; once accepted, the first two months are non-refundable. From month three it is $299 month to month, cancel any time.
For a professional already paying a high-deductible premium, this is not a replacement for your insurance plan. It is the clinical relationship your plan never includes, and our piece on paying cash for primary care on a high-deductible plan explains how the two fit together.
Who this is not for
If you want the wellness-points credit and nothing else, your employer already provides that, cheaper than we can. If you need emergency care, surgery, or hospital-level management, the membership is not the instrument and we will say so during eligibility review. What we are built for is the person whose screening said fine, whose body said otherwise, and who is done taking the screening's word for it.
FAQ
What does a corporate biometric screening actually test?
Typically height, weight or BMI, blood pressure, fasting glucose or HbA1c, and a basic lipid panel with LDL, HDL and triglycerides. It takes about ten minutes, produces a benefit-reporting score, and includes no clinician review or follow-up.
Can my labs be normal and my heart risk still be high?
Yes, and the hospital data proves it. In the Get With The Guidelines analysis of 136,905 coronary hospitalizations, nearly half of admitted patients had admission LDL below 100 mg/dL. The basic panel estimates the risk carriers; ApoB and Lp(a) measure them directly, and neither is on a standard screening.
What should I check after a normal workplace screening?
The markers the screening skips: ApoB, Lp(a), fasting insulin, hs-CRP, and full thyroid and hormone panels. Those are the layers where cardiometabolic risk and the symptoms a normal screening cannot explain usually live.
Is a wellness program the same as primary care?
No. A wellness program is an employer benefit built around screening events and incentives. Primary care is a clinical relationship with a named clinician who knows your history, orders the right follow-up, and treats what the panel finds. The screening replaces neither.
Does GoodLife Health work with my insurance?
The membership is cash-pay and sits outside your insurance plan entirely. You keep your coverage for what it covers and use the membership for the clinical relationship, the quarterly Biomarker Audit, and prescriptions at the pharmacy's own cost.
What does the $299 monthly fee include?
A comprehensive Biomarker Audit every 90 days (ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers, full hormone and thyroid panels), the clinician relationship, and prescriptions at the pharmacy's cost with zero markup. The first charge is $598 for the first two months, held on your card at sign-up and never charged if the clinician cannot accept you into care.
Related reading
- Cardiometabolic Optimization: The Definitive Guide
- High-deductible health plan: paying cash for primary care
- The best labs to request at a metabolic health checkup
- Membership pricing
- Check your eligibility
References
- Sachdeva et al., Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines, Am Heart J 2009;157:111-117. 2009. pubmed.ncbi.nlm.nih.gov/19081406/